CST3 and triple-A syndrome: In the AAA risk score including blood biomarkers (N=309 077 participants, n=1237 AAA events in the derivation cohort; N=65 591 participants, n=236 AAA events in the validation cohort; Tables III and IV in the Data Supplement), diabetes was no longer included in the predictive model, but higher C-reactive protein, higher low-density lipoprotein cholesterol, lower high-density lipoprotein cholesterol, higher Lp(a), higher cystatin-C, lower alanine aminotransferase, and lower platelet count were all associated with increased risk of AAA (Table V in the Data Supplement).